Insights from 2023 ASCO® Annual Meeting

 

GI
05:27

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Post Hoc Analysis of Patients With Nonviral Etiology From REFLECT Trial - Efficacy of Lenvatinib vs. Sorafenib in the 1L Treatment of Patients With Unresectable HCC"

FEATURING Ari Baron
  • 70 views
  • July 17, 2023
05:51

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "KEYNOTE-859 Study of Pembro + Chemo for Advanced HER2- GC/GEJC - Outcomes in the Protocol-Specified PD-L1-Selected Populations"

FEATURING Sun Young Rha
  • 148 views
  • July 11, 2023
  • 1
08:16

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Primary Results From the Multicenter, Randomized, Phase 2 DESTINY-CRC02 Study - T-DXd in Patients With HER2+ mCRC"

FEATURING Kanwal Raghav
  • 67 views
  • July 11, 2023
08:56

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Final Survival Outcomes of the Randomized Phase 3 PRODIGY Trial - Neoadjuvant Docetaxel, Oxaliplatin, & S-1 + Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer"

FEATURING Yoon-Koo Kang
  • 121 views
  • July 11, 2023
  • 1
05:54

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 3 PANOVA-3 Study - TTF Therapy Concomitant With Gemcitabine & nab-Paclitaxel for Frontline Treatment of Locally Advanced Pancreatic Cancer"

FEATURING Hani Babiker
  • 232 views
  • July 2, 2023
  • 1
05:58

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 3 STELLAR-303 Study - XL092 in Combination With Atezo vs. Regorafenib in Previously Treated mCRC"

FEATURING J. Randolph Hecht
  • 45 views
  • July 2, 2023
04:35

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Alliance A021806 Data on Perioperative vs. Adjuvant Therapy for Resectable Pancreatic Cancer"

FEATURING Akhil Chawla, Cristina Ferrone
  • 310 views
  • June 26, 2023
  • 2
20:07

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials Including PROSPECT, ATTRACTION-5 & NAPOLI-3"

FEATURING Yelena Janjigian, Samuel Cytryn, Steven Maron
  • 1,602 views
  • June 23, 2023
  • 9
11:32

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Perioperative PD-1 Antibody Toripalimab + SOX / XELOX Chemo vs. SOX or XELOX Alone for Locally Advanced GC / GEJC"

FEATURING Shuqiang Yuan
  • 34 views
  • June 23, 2023
02:38

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Analysis of SUNLIGHT Trial on Trifluridine / Tipiracil + Bevacizumab in Refractory mCRC"

FEATURING Julien Taieb
  • 132 views
  • June 23, 2023
  • 1
10:43

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "FGFR 2.0 in BTC - Is There a Best in Class?"

FEATURING Arndt Vogel
  • 216 views
  • June 21, 2023
  • 1
07:21

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "KRYSTAL-1 Trial - Activity & Safety of Adagrasib in Patients with Advanced Solid Tumors Harboring a KRASG12C Mutation"

FEATURING Shubham Pant
  • 92 views
  • June 21, 2023
  • 1
09:14

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Results From the Pivotal Phase 2b HERIZON-BTC-01 Study - Zanidatamab in Previously-Treated HER2‑Amplified Biliary Tract Cancer"

FEATURING Shubham Pant
  • 92 views
  • June 21, 2023
  • 1
06:32

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "STAR-221 Phase 3 Trial - Domvanalimab, Zimberelimab, & Chemo vs. Nivo & Chemo in Previously Untreated, Locally Advanced, Unresectable or Metastatic GC/GEJC/EC"

FEATURING Samuel Klempner
  • 250 views
  • June 15, 2023
  • 1
09:13

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "The Randomized Phase 3 CAIRO4 Study of the Dutch CRC Group - Upfront Palliative Resection of Primary Tumor vs. No Resection in Pts With Synchronous mCRC"

FEATURING Dave Van Der Kruijssen
  • 226 views
  • June 15, 2023
  • 1
06:05

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Updated Results From the GALAXY Study in the CIRCULATE-Japan - ctDNA Dynamics as an Early Predictor of Recurrence in Pts With Radically Resected CRC"

FEATURING Eiji Oki
  • 440 views
  • June 15, 2023
  • 1
11:09

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase 2 Basket Study of Tucatinib & Trastuzumab for Previously Treated HER2+ Metastatic Biliary Tract Cancer (SGNTUC-019)"

FEATURING Yoshiaki Nakamura
  • 119 views
  • June 15, 2023
10:09

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "The NeoCol Phase III Randomized Clinical Trial - Comparing the Efficacy of Neoadjuvant Chemo & Standard Treatment in Pts With Locally Advanced Colon Cancer"

FEATURING Lars Henrik Jensen
  • 231 views
  • June 15, 2023
06:26

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "64-Month Follow-Up From CheckMate 142 - 1L Nivo + Ipi in Pts With MSI-H/dMMR mCRC"

FEATURING Heinz-Josef Lenz
  • 763 views
  • June 15, 2023
11:57

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase III FIRE-4 Study - Influence of Baseline Liquid Biopsy Results in 1L Treatment Efficacy of FOLFIRI/Cetuximab in Pts With Tissue RAS-WT mCRC"

FEATURING Sebastian Stintzing
  • 876 views
  • June 15, 2023
  • 3
08:35

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 3 ATTRACTION-5 Study - Nivo + Chemo as Postoperative Adjuvant Treatment for Pathological Stage III G/GEJ Cancer"

FEATURING Masanori Terashima
  • 366 views
  • June 14, 2023
  • 4
11:05

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Efficacy, Safety, & PROs From the Phase III IMbrave050 Trial - Adjuvant Atezo + Bev vs. Active Surveillance in HCC Patients With High Risk of Disease Recurrence Following Resection or Ablation"

FEATURING Masatoshi Kudo
  • 281 views
  • June 14, 2023
  • 1
04:18

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Biomarker Analysis of 2 Zolbetuximab Phase 3 Studies (SPOTLIGHT & GLOW) - Global Prevalence of CLDN18.2 in Locally Advanced Unresectable/Metastatic Gastric/GEJ Adenocarcinoma"

FEATURING Kohei Shitara
  • 509 views
  • June 12, 2023
  • 1
22:55

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON-BTC-01 & MORPHEUS-Liver"

FEATURING Richard Kim, Rutika Mehta
  • 3,149 views
  • June 9, 2023
  • 14